<img alt="" height="1" width="1" />Ironwood underwriters bump up IPO proceeds to $203MMass High TechThe company will use those funds to develop and commercialize linaclotide, its treatment of irritable bowel syndrome with constipation (IBS-C) and chronic ...Ironwood Pharmaceuticals says underwriters exercise overallotment option<nobr>CanadianBusiness.com</nobr>Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals ...<nobr>MarketWatch (press release)</nobr><nobr>all 22 news articles »</nobr> |